Clinical trial
High-Dose Vitamin E (Alpha-Tocopherol) Supplementation To Reduce C-Reactive Protein In Patients With COVID-19
NCT07412574 is registered in ClinicalTrials.gov with Universidad Veracruzana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High-Dose Vitamin E (Alpha-Tocopherol) Supplementation To Reduce C-Reactive Protein In Patients With COVID-19
- Lead sponsor
- Universidad Veracruzana
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 27, 2020
- Completion date
- September 27, 2021
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid - 19